Track topics on Twitter Track topics that are important to you
At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development of the INTERCEPT Blood Systems to inactivate viruses, bacteria and other pathogens in the blood components used for transfusion - platelets, plasma and red blood cells.
2411 Stanwell Drive
United States of America
Phone: (925) 288-6000
Fax: (925) 288-6001
Cerus has exercised additional options with the Biomedical Advanced Research and Development Authority for studies of INTERCE -More-
Cerus Corporation (NASDAQ:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, is scheduled to present a corporate update at the ...
European regulators have given Cerus Endovascular CE mark approval for its Contour neurovascular system, a device intended fo -More-
Cerus Corporation (NASDAQ:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, will present at two upcoming conferences: ...
Cerus Corporation (NASDAQ:CERS) announced today that its second quarter results will be released on Thursday, August 3, 2017, after the close of the stock market. The company will...
Cerus Endovascular Ltd. today announced that it has received CE Mark approval for the commercial sale of its Contour Neurovascular System™ for the treatment of intra-cranial aneurysms (IAs) across t...
Cerus reported that additional options totaling $46.6M have been exercised under its contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of He...
At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development o...
Condensed Consolidated Unaudited Balance Sheets
We have published hundreds of Cerus news stories on BioPortfolio along with dozens of Cerus Clinical Trials and PubMed Articles about Cerus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cerus Companies in our database. You can also find out about relevant Cerus Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells. In vertebrates, it is composed of blo...